Lyfjastofnun | Reykjavík, also known as the Icelandic Medicines Agency (IMA), is dedicated to ensuring the quality and safety of medicines and medical devices for patients and the general public. They play a crucial role in regulating the development, marketing authorizations, and pricing and reimbursement of medicinal products. For medicinal products, Lyfjastofnun | Reykjavík provides comprehensive information on the medicines available in the market, including their side effects.

They also offer the opportunity for individuals to report any adverse drug reactions they may experience. In addition, they oversee the regulatory surveillance of medical devices, ensuring their proper use and vigilance. The agency also offers guidance on clinical trials and scientific advice to support the development of new medicinal products.

Lyfjastofnun | Reykjavík plays a vital role in the entire healthcare ecosystem, working with regulated entities such as manufacturers, medical centers, pharmacies, and wholesalers. They also publish important materials, guidelines, and news to keep the public informed. With its commitment to quality, trust, and service, Lyfjastofnun | Reykjavík strives to keep the public well-informed and ensure the safety of medicines and medical devices in Iceland